Givaudan has completed the acquisition of a portfolio of biofermented cosmetic ingredients for its Active Beauty business from US firm Amyris.
The ingredients include Neossance Squalane emollient, Neossance Hemisqualane plant-based silicone alternative and CleanScreen sustainable sun protector.
Terms of the deal, which was first announced in February, were not disclosed but Amyris’ cosmetic business would have represented approximately $30m of incremental sales to Givaudan’s results in 2022 on a proforma basis.
Givaudan funded the transaction from existing resources.
The Swiss firm said it has a strong partnership with Amyris to leverage the value of the latter’s technology platform for “designing, scaling and manufacturing the best performing biofermented ingredients”.
“It is an important step for Givaudan as we will reinforce our leadership in biotech, while continuing to offer efficient and sustainable solutions for the beauty industry, thanks to our long-standing partnership with Amyris,” added Givaudan Fragrance & Beauty president Maurizio Volpi.
“The complementary nature of both capabilities will further enhance our ability to support our customers with breakthrough innovations.”
Markus Rassmann, Head of Active Beauty, said: “We are delighted to enrich our market-leading biotech cosmetic ingredients portfolio with the Amyris products. With this acquisition we enhance our unique biotech palette, leading the market towards a more sustainable future.”
